Anteilseigner
OrbiMed Advisors Private Equity (26,12 %) Baker Bros. Advisors LP (24,05 %) Deerfield Management Co. LP (Private Equity) (9,82 %) Boxer Capital LLC (6,10 %) The Vanguard Group, Inc. (2,39 %) BlackRock Fund Advisors (2,20 %) T. Rowe Price Associates, Inc. (Investment Management) (2,20 %) Paul A. Friedman (1,21 %) Massachusetts Financial Services Co. (1,21 %) Geode Capital Management LLC (0,86 %) Sio Capital Management LLC (0,76 %) Morgan Stanley Smith Barney LLC (Investment Management) (0,58 %) Renaissance Technologies LLC (0,58 %) SSgA Funds Management, Inc. (0,50 %) TD Asset Management, Inc. (0,38 %) Charles Schwab Investment Management, Inc. (0,30 %) Bridgeway Capital Management LLC (0,29 %) Northern Trust Investments, Inc.(Investment Management) (0,29 %) Millennium Management LLC (0,24 %)
Kontakt
Prelude Therapeutics Inc.